破解高值药支付困局!商保创新药目录满月考,专家:“以量换价”或需替代机制

时代周报
Aug 13, 2025

8月11日,复星医药控股子公司与Expedition Therapeutics签订协议,授予DPP-1抑制剂XH-S004的全球开发及商业化权(除中国内地及港澳地区),Expedition支付至多1.2亿美元首付款、开发里程碑款及5.25亿美元销售里程碑款。不久前的7月28日,恒瑞医药与葛兰素史克(GSK)签署协议,许可HRS-9821及至多11个项目的全球独家权利(除中国内地及港澳台地区),获得...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10